Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S ADR
WKN: 866931 / Symbol: NVO / Name: Novo Nordisk / Aktie / Pharmazeutika / Large Cap /
41,70 €
-2,68 %
Novo Nordisk A/S (NYSE:NVO) was upgraded by analysts at Berenberg Bank from a "hold" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat
Novo Nordisk A/S (NYSE:NVO) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "underweight" rating. They now have a $47.00 price target on the stock, down previously from $59.00.
Ratings data for NVO provided by MarketBeat
Novo Nordisk A/S (NYSE:NVO) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat
Novo Nordisk A/S (NYSE:NVO) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $60.00 to $54.00. They now have a "buy" rating on the stock.
Ratings data for NVO provided by MarketBeat
Neueste Beiträge
BTIG_Research in Workday, Inc. diskutieren